Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

Edison Notes "Improved Performance" From Biotech Growth Trust

Fri, 24th Jan 2020 18:20

(Alliance News) - Biotech Growth Trust PLC on Friday noted a report from Edison highlighting a "much-improved investment performance" of late.

The report was commissioned by biotechnology sector investor Biotech Growth, a client of research and advisory firm Edison.

Edison said the trust's managers at OrbiMed Capital, Geoff Hsu and Richard Klemm, "are very encouraged by the trust's much-improved investment performance in recent months, noting they are being rewarded by the market for their in-depth fundamental research and portfolio positioning in favour of emerging rather than large-cap biotech stocks."

Biotech Growth's benchmark is the NASDAQ Biotechnology index, sterling adjusted, which its net asset value has outperformed over the last one, three, five, and ten years.

At present, Biotech Growth's share are trading at a 9.1% discount to cum-income NAV, worse than the 5.4% to 7.9% range from the last one, three, five, and ten years. Shares in Biotech Growth closed down 1.3% at 928.00 pence on Friday.

"There is scope for a higher valuation given the meaningful recent improvement in the trust's performance. The board actively repurchases shares, aiming for a maximum 6% discount in normal market conditions," said Edison.

According to Edison, Hsu said biotech stocks in 2019 are currently being influenced by the political backdrop in the US, especially in terms of Democratic Party candidate nominees.

While former vice president Joe Biden is currently frontrunner, there are concerns that candidates like Bernie Sanders or Elizabeth Warren might put pressure on the sector as part of healthcare reform.

There are also concerns around US price regulation, with proposed policies like international reference pricing for Medicare drugs, inflation-based price caps, and letting Medicare negotiate prices directly with pharmaceutical firms.

Hsu, however, told Edison he was not expecting "any dramatic changes to US drug pricing policy" even if a Democratic president wins as the US Congress is likely to stay split and political pressure on healthcare is likely to abate in 2020.

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News
10 Nov 2023 14:22

Biotech Growth's total return underperforms benchmark in tough market

(Alliance News) - Biotech Growth Trust PLC on Thursday said its net asset value decreased with a negative return in its latest half year, lamenting th...

15 Jun 2023 11:56

Biotech Growth Trust net assets drop after "another difficult year"

(Alliance News) - Biotech Growth Trust on Thursday said its net asset value per share declined during financial 2023 and produced a negative return, w...

15 Jun 2023 09:40

SMALL-CAP WINNERS & LOSERS: Biotech Growth underperforms benchmark

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday.

16 Nov 2022 14:54

EARNINGS SUMMARY: Biotech Growth, Dunedin Enterprise net assets grow

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Wednesday and not separately reported by Alliance News...

12 Jul 2022 15:39

UK shareholder meetings calendar - next 7 days

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.